http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
TEMAZEPAM 4381 14-Sep-81 DINAMITE DIPHARMA SPA METOCLOPRAMIDE HYDROCHLORIDE BP'80 4395 25-Nov-81 DANISCO INGREDIENTS BUTALBITAL 4397 22-Dec-81 HOVIONE SOCIEDADE QUIMICA LDA BETAMETHASONE 17-VALERATE 4416 23-Jan-82 LABORATORIO CHIMICO INTERNATIONAL SPA CARISOPRODOL 4420 03-Feb-82 SOCIETA ITALIANA CORTICOSTEROIDI SPA DESONIDE 4423 03-Feb-82 AVENTIS PHARMA SA FLUOROMETHOLONE...
http://www.fda.gov/cder/dmf/xls/4Q2003ACTIVETYPE2EXCEL.xls
URSODEOXYCHOLIC ACID MEDIMPEX INC ALPHA METHYLDOPA USP XIX BULK AS MFG BY EGIS PHARMACEUT WORKS BUDAPEST ACRAF TRAZODONE HCL ROCHE COLORADO CORPORATION BUTOCONAZOLE NITRATE GEDEON RICHTER LTD NORETHISTERONE DINAMITE DIPHARMA SPA FUROSEMIDE USP SCHERING AG ESTRADIOL-VALERATE SCHERING AG TESTOSTERONE ENANTHATE PROQUINA SA PIPERAZINE ESTRONE SULFATE MERCK AG METHYL GLUCAMINE ...
Alefacept (Amevive) Clinical Review page 26
author: CBER FDA
subject: dob062703
Prescription and OTC Drug Product List 8/2001
ACTHAR GEL -D- BC + AVENTIS 40 UNITS/ML N08372 006 FEB 06, 1956 AUG CAHN -D- BC + 80 UNITS/ML N08372 008 FEB 06, 1956 AUG CAHN -A- BC + QUESTCOR PHARMS 40 UNITS/ML N08372 006 FEB 06, 1956 AUG CAHN -A- BC + 80 UNITS/ML N08372 008 FEB 06, 1956 AUG CAHN DELAVIRDINE MESYLATE TABLET; ORAL RESCRIPTOR -D- + AGOURON 100MG N20705 001 APR 04, 1997 AUG CRLD -A- 100MG N20705 001 APR 04, 1997 AUG...
SSCI Inc.: X-ray Powder Diffraction, Raman and Infrared Spectroscopy, Differential Scanning Calorimetry, and Thermogravimetric
Phone: 800 375-2179 / 765 463-0112 Fax: 765 497-2649 / 765 463-4722 E-mail: info@ssci-inc.com SSCI Inc., 3065 Kent Avenue, West Lafayette, IN 47906 - 1076 USA Acetaminophen Acetazolamide Acetohexamide Acetylcysteine Acyclovir Adenine L-Alanine Albuterol Albuterol Sulfate Allopurinol Alprazolam Amantadine HCl Amiloride HCl Aminobenzoic Acid Aminoglutethimide Aminosalicylic Acid...
author: SSCI Webmaster
ranbaxy
- - - - - - You are here :- Home - Products - - Dosage Forms - INDIA DOSAGE FORMS LIST- (Updated Jan 2002) Anti-infectives G.I. & Nutritionals CVS & Diabetes CNS NSAID & related Anti-allergants ...
FDA Drug Approvals List- February 1999
Applicant: CONNETICS CORP Active Ingredient(s): BETAMETHASONE VALERATE OTC/RX Status: RX Indication(s):For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp Original Application #: 020969 Approval Date: 25-FEB-99 Trade Name: UVADEX Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant:...
http://www.raps.org/pdf/ac/2001/Johnston_G_505b2_NDA_Tues_800.pdf
The 505( b)( 2) NDA: What Is It & How Do You Use It RAPS 2001 Annual Conference Baltimore, Maryland November 4- 7, 2001 Gordon Johnston, M. S., R. Ph. Lachman Consultant Services, Inc. ...
FDA Drug Approvals List November 2000
Active Ingredient(s): VINORELBINE TARTRATE OTC/RX Status: RX Application #: 018936 Labeling Supplement #: 063 To Original New Drug Application Approval Date: 28-NOV-00 Trade Name: PROZAC Dosage Form: CAPSULE Applicant: LILLY RESEARCH LABORATORIES DIV ELI LILLY AND CO Active Ingredient(s): FLUOXETINE HYDROCHLORIDE OTC/RX Status: RX Application #: 018936 Labeling Supplement #: 062 To...
C:\Data\My Documents\NDA\9402\slr37.ap.doc
NDA 09- 402/ S- 037 and 039 Page 3 DELESTROGEN ® (ESTRADIOL VALERATE INJECTION, USP) ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important Estrogens act to reduce the elevated levels of these hormones seen in postmenopausal women NDA 09- 402/ S- 037 and 039 Page 6 Inducers of CYP3A4 such as St
author: Kassandra C. Sherrod
C:\Data\My Documents\NDA\9402\slr37.ap.doc page 1
author: Kassandra C. Sherrod
duplicates:http://www.fda.gov/cder/foi/label/2003/09402slr037_delestrogen_lbl.pdf
1996 and Older - New Drug Application (NDA)
New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office 20195/S-002 5/20/96 8/2/99 Fragmin/dalteparin sodium Injection [1.5 MB] Pharmacia and Upjohn 020287/S005 9/24/1996 2/4/1998 Heptolite, Kit for the Preparation of Technetium Tc 99m Disofenin Merck 18467/ S-13 & S-14 12/29/1993 8/5...
C:\Data\My Documents\NDA\9402\slr37.ap.doc
NDA 09- 402/ S- 037 and 039 Page 3 DELESTROGEN ® (ESTRADIOL VALERATE INJECTION, USP) ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important Estrogens act to reduce the elevated levels of these hormones seen in postmenopausal women NDA 09- 402/ S- 037 and 039 Page 6 Inducers of CYP3A4 such as St
author: Kassandra C. Sherrod
http://www.euroscreen.be/PDF/GPR43.pdf
Functional Characterization of Human Receptors for Short Chain Fatty Acids and Their Role in Polymorphonuclear Cell Activation* Received for publication, February 10, 2003, and in revised form, April 22, 2003 Published, JBC Papers in Press, April 23, 2003, DOI 10.1074/ jbc GPR43 GPR41 Carbon cAMP Ca 2 cAMP Ca 2 Formate 1 2.61 0.06 (8) 1.99 0.03 (8) 10 mM (10) 10 mM (10) Acetate 2...
http://www.euroscreen.be/PDF/GPR43.pdf page 6
ANDAs Approvals - May 2000
Food and Drug Administration Center for Drug Evaluation and Research Drug Information Search Office Of Generic Drugs ANDAs Approvals May 2000 - 1 5/1/00 TABLETS 80 MG 120 MG 160 MG 240 MG 2 75-429 SOTALOL HYDROCHLORIDE TEVA PHARMACEUTICALS USA 5/1/00 TABLETS 80 MG 120 MG 160 MG 240 MG 4 5/2/00 ATROPINE SULFATE TABLETS, USP 2.5 MG/0.025 MG 5 5/4/00 (OTC) 75 MG 7
author: USERNAME
75043_Hydrocortisone.htm
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Hydrocortisone Valerate Ointment, USP Company:- Taro Pharmaceuticals Inc Application No.:- 75-043 Approval Date:-8/25/1998 - Approval Letter(s) - Printed Labeling - Chemistry Review(s) - Bioequivalence Review(s) - Administrative Document(s) - Correspondence - - Back to Drug...
author: Paul Stauffer
74489_Hydrocortisone.htm
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Hydrocortisone Valerate Cream, USP Company:- Copley Pharmaceutical, Inc Application No.:- 74-489 Approval Date:-8/12/1998 - Approval Letter(s) - Printed Labeling - Chemistry Review(s) - Bioequivalence Review(s) - Administrative Document(s) - Correspondence - - Back to Drug...
author: Paul Stauffer
http://www.repromed.com.au/DOCUMENTS/statement.pdf
Information Statement Table of Contents i Welcome to 1 Out of Hours Contact 1 Legal Aspe 2 Health and 4 Counselling and Support 5 Medications 6 Ovulation 8 Intra Uterine Insemination 10 Donor Sperm Program (DI) 12 IVF, ICSI Treatment 13 § How many eggs to be Inseminated Limit on Number of Embryos The licensee is not permitted by law to place more than three embryos in a woman...
Prescription and OTC Drug Product List 7/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE -A- AB ABLE 325MG;50MG;40MG N40390 001 JUL 23, 2001 JUL NEWA -A- AB 500MG;50MG;40MG N40394 001 JUL 23, 2001 JUL NEWA ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA + WATSON LABS 325MG;7.5MG...
Prescription and OTC Drug Product List 12/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACARBOSE TABLET; ORAL PRECOSE -D- BAYER 25MG N20482 004 MAY 29, 1997 DEC CAHN -D- 50MG N20482 001 SEP 06, 1995 DEC CAHN -D- + 100MG N20482 002 SEP 06, 1995 DEC CAHN -A- BAYER PHARMS 25MG N20482 004 MAY 29, 1997 DEC CAHN -A- 50MG N20482 001 SEP 06, 1995 DEC CAHN -A- + 100MG N20482 002 SEP 06, 1995 DEC CAHN ACYCLOVIR -A- CREAM;...
Contents Vol. 18, No. 6, 2002
CONTENTS New Drugs and Profile Reports Estradiol Valerate/ Dienogest: profile report* 1 Disease Management Start DMARDs early in patients with rheumatoid arthritis 3 A multi- pronged approach required for management of complications of cirrhosis of the liver 8 ACE inhibitors prove beneficial for an increasing range of complications of diabetes mellitus 11 Lipid abnormalities...
author: Adis International Limited
subject: Drugs & Therapy Perspectives
Curriculum Vitae of Dr. Reza Fassihi, PhD, HPA
Curriculum Vitae of Dr. Reza Fassihi, discoverer of the patented Controlled Delivery Technology platform Addresses for Correspondence: Work: Temple University - School of Pharmacy - 3307 N. Broad ...
Contents Vol. 62 No. 3, 2002
Contents Leading Article Oral Loading with Propafenone for Conversion of Recent- Onset Atrial Fibrillation: A Review on In- Hospital Treatment 415- 423 G Boriani, C Martignani, M Biffi, A Capucci, A Branzi Review Articles Treatment Options for Vancomycin- Resistant Enterococcal Infections 425- 441 PK Linden Rationale for Fixed- Dose Combinations in the Treatment of Hypertension: The...
author: Adis International Limited
subject: Drugs